Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Mats Ohlin, Ph.D.

Professor, Department of Immunotechnology & SciLifeLab at Lund University


1993: PhD in Immunotechnology. Thesis title: "Human monoclonal antibody technology. A tool to investigate human antibody repertoires".1995: Associate Professor of Immunotechnology at Lund University.2003: Professor of Immunotechnology at Lund University.2008: Awarded the distinction "Excellent Teaching Practitioner" at Lund School of Technology, the engineering faculty at Lund University.2016: Facility Director of Science for Life Laboratory's Human Therapeutic Antibody facility at Lund University.Five major scientific achievements:1. Built the largest available collection of human patients' recombinant IgE.2. Defined critical aspects of human IgE repertoires and their development in allergy and allergen-specific immunotherapy.3. Defined critical features of the immune response against cytomegalovirus gB.4. Defined critical features of protein-carbohydrate interaction using combinatorial library technology and structure determination. This was in part achieved through development of the first structure of a carbohydrate binding module/ligand complex determined using neutron crystallography.5. Designed a platform for antibody development using combinatorial library technology

Agenda Sessions